The store will not work correctly when cookies are disabled.
6-(3-(4-methylpiperazin-1-yl)propoxy)-4H-chromen-4-one
ID: ALA4760964
PubChem CID: 162660079
Max Phase: Preclinical
Molecular Formula: C17H22N2O3
Molecular Weight: 302.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CN1CCN(CCCOc2ccc3occc(=O)c3c2)CC1
Standard InChI: InChI=1S/C17H22N2O3/c1-18-7-9-19(10-8-18)6-2-11-21-14-3-4-17-15(13-14)16(20)5-12-22-17/h3-5,12-13H,2,6-11H2,1H3
Standard InChI Key: GEOHNFXJNSSCCM-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
14.7564 -12.1551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7552 -12.9820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4696 -13.3946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4678 -11.7427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1827 -12.1515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1815 -12.9841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8980 -13.3991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6203 -12.9862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6214 -12.1536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9004 -11.7340 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.8922 -14.2236 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0374 -13.3961 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.3235 -12.9836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6093 -13.3956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8954 -12.9831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1813 -13.3951 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4707 -12.9816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7587 -13.3902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7541 -14.2150 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4678 -14.6297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1861 -14.2195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0384 -14.6243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
7 11 2 0
2 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
19 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 302.37 | Molecular Weight (Monoisotopic): 302.1630 | AlogP: 1.81 | #Rotatable Bonds: 5 |
Polar Surface Area: 45.92 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.89 | CX LogP: 1.44 | CX LogD: 0.83 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.79 | Np Likeness Score: -0.67 |
References
1. Deuther-Conrad, Winnie, Diez-Iriepa, Daniel, Iriepa, Isabel, Lopez-Munoz, Francisco, Martinez-Grau, Maria Angeles, Gutschow, Michael, Marco-Contelles, Jose. (2021) Studies on the affinity of 6-[(n-(cyclo)aminoalkyl)oxy]-4H-chromen-4-ones for sigma 1/2 receptors, 12 (6.0): [PMID:34223165] [10.1039/d1md00105a] |